Disc Medicine (IRON) Liabilities and Shareholders Equity (2020 - 2026)

Disc Medicine (IRON) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $735.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 10.53% year-over-year to $735.1 million; the TTM figure through Jun 2026 stood at $2.9 billion (up 23.51% YoY), while the FY2025 annual figure was $806.9 million, up 62.42% from the prior year.
• Liabilities and Shareholders Equity declined to $735.1 million in Q2 2026 per IRON's latest filing, from $750.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $806.9 million in Q4 2025 and bottomed at $106.0 million in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $448.3 million across 5 years, with a median of $439.7 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity tumbled 34.37% — and 2023, when it soared 255.08%.
• Disc Medicine's Liabilities and Shareholders Equity stood at $200.2 million in 2022, then jumped by 83.81% to $368.0 million in 2023, then soared by 34.99% to $496.8 million in 2024, then jumped by 62.42% to $806.9 million in 2025, then dropped by 8.9% to $735.1 million in 2026.
• Business Quant data shows IRON's Liabilities and Shareholders Equity at $735.1 million in Q2 2026, $750.2 million in Q1 2026, and $806.9 million in Q4 2025.